Genmab — Maj 2018
-
Pensionisten ,, håber du har ret, så vi kan se lidt normale tilstande med køb / salg... så kan vi bare vente på at den stiger lidt så de skal til at købe tilbage
-
Den øgede aktivitet, skyldes det "Potentiel FDA godkendelse af Darzalex + VMP i nydiagnosticeret knoglemarvskræft " den 21. Maj. Eller er denne allerede indregnet i kursen? God aften
-
@Pensionisten. Hvorfor tror du ikke de kan låne flere ? Tror du AQR har en intern regel og de ikke må shorte mere end 2.3% i enkelt aktier ? eller er der ikke nogen der vil/må
låne dem aktier ?? -
God morgen.
-
This Nivolumab / BMS study now takes out Pomalidomide, Dexamethasone , Currently, this study is only open to nivolumab+daratumumab vs daratumumab monotherapy https://clinicaltrials.gov/ct2/history/NCT01592370?A=60&B=61&C=Side-by-Side
-
Potential of VRD + Daratumumab in Myeloma - http://www.targetedonc.com/case-based-peer-perspectives/multiple-myeloma/chari-myeloma-treatment/potential-of-vrd-daratumumab-in-myeloma
-
I find this very interesting "for example, when VMP was approved many years ago, oncologists took that to be able to use bortezomib frontline, but many people weren’t necessarily giving the melphalan with it" http://www.targetedonc.com/case-based-peer-perspectives/multiple-myeloma/chari-myeloma-treatment/use-of-vmp-daratumumab-in-myeloma
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind